The biomarker pTau 217 is associated with Alzheimer’s disease pathology and can be detected in plasma, providing a minimally invasive option to support other diagnostic tests. |
April 21, 2025 |
ARUP Launches pTau 217 Blood Test To Detect Alzheimer’s Disease Pathology ARUP Laboratories now offers a test for pTau 217 to aid in the detection of Alzheimer’s disease pathology. This test |
The U.S. District Court for the Eastern District of Texas today struck down the FDA’s final rule to regulate laboratory-developed tests. |
March 31, 2025 |
ARUP Applauds Federal Court Decision Vacating the FDA’s Final Rule Regulating… The rule and its compliance deadlines are no longer in effect, benefiting patient care, |
March 11, 2025 |
Pramana and ARUP Laboratories Partner To Digitize Pathology Slides and Develop AI-Powered… Pramana, Inc., and ARUP are collaborating to improve the assessment of bone marrow biopsies and address |
|
The robotic arm removes the wet-mount specimen slide in preparation for scanning. Once scanned, the image will be screened via artificial intelligence (AI) for evidence of ova and parasites. |
March 6, 2025 |
ARUP Laboratories Expands AI-Augmented Parasitology Screening Tool, Improves Detection and Diagnosis ARUP will expand its AI-augmented screening tool for the detection of human gastrointestinal |
The partnership combines Tasso’s clinical grade blood collection solutions, such as the Tasso+ device pictured above, with ARUP’s gold standard testing capabilities to streamline and accelerate decentralized clinical research. |
February 3, 2025 | The partnership combines Tasso’s clinical grade blood collection solutions and ARUP’s gold |
ARUP’s new assay, Influenza A (H5) Virus by Qualitative NAAT (ARUP test number 3018970), will expand the national capacity to detect the current outbreak of highly pathogenic avian influenza A (H5N1). |
January 3, 2025 | ARUP has launched a new assay for the detection and subtyping of influenza A (H5) virus, which will expand the national capacity to detect the |